CERETEC .5 mg/5mL
TECHNETIUM TC-99M EXAMETAZIME · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Medi-Physics Inc. dba GE Healthcare.
CERETEC is a injection, powder, lyophilized, for solution containing technetium tc-99m exametazime at .5 mg/5mL, taken intravenous. Manufactured by Medi-Physics Inc. dba GE Healthcare..
Key Facts
- Brand Name
- CERETEC
- Generic Name
- TECHNETIUM TC-99M EXAMETAZIME
- NDC Code (Product)
17156-022- Manufacturer
- Medi-Physics Inc. dba GE Healthcare.
- Strength
- .5 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA019829
- Drug Class
- Radioactive Diagnostic Agent [EPC]
- Marketing Start
- 12/30/1988
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Technetium Tc99m exametazime scintigraphy may be useful as an adjunct in the detection of altered regional cerebral perfusion in stroke. Tc99m exametazime is indicated for leukocyte labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.
Dosage & Administration
DOSAGE AND ADMINISTRATION Tc99m labeled leukocytes for adjunctive localization of intra-abdominal infection or inflammation. The normal adult (70 kg) dose is 0.259-0.925 GBq (7-25 mCi) as Tc99m labeled leukocytes by intravenous injection. Optimal planar imaging is between 2-4 hours. Cerebral Scintigraphy The recommended dose range for i.v. administration, of reconstituted sodium pertechnetate Tc99m exametazime in the average adult (70 kg) is 370-740 MBq (10-20 mCi). Dynamic imaging may be performed between 0 to 10 minutes following injection. Static imaging may be performed from 15 minutes up to 6 hours after injection.
Contraindications
CONTRAINDICATIONS None known.
Adverse Reactions
ADVERSE REACTIONS Rash with generalized erythema, facial edema and fever has been reported in less than 1% of patients. A transient increase in blood pressure was seen in 8% of patients.
Frequently Asked Questions
What is CERETEC used for?
CERETEC contains TECHNETIUM TC-99M EXAMETAZIME. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is CERETEC a controlled substance?
CERETEC is not classified as a controlled substance by the DEA.
What is the generic name for CERETEC?
The generic name for CERETEC is TECHNETIUM TC-99M EXAMETAZIME. There are 1 other brand versions of TECHNETIUM TC-99M EXAMETAZIME.
What is the NDC code for CERETEC .5 mg/5mL?
The NDC (National Drug Code) for CERETEC .5 mg/5mL is 17156-022, listed by Medi-Physics Inc. dba GE Healthcare..